Table 2.
Baseline characteristics of participants associated with coronary disease (CHD)
| Variable | CHD, N = 6791 | CON, N = 15,6081 | p-value2 |
|---|---|---|---|
| AGE, Median (IQR) | 70.00 (63.00–79.00) | 48.00 (33.00–63.00) | < 0.001 |
| PIR, Median (IQR) | 2.15 (1.20–3.92) | 2.15 (1.13–4.09) | 0.7 |
| TC, Median (IQR) | 166.00 (141.00–198.00) | 191.00 (165.00–218.00) | < 0.001 |
| A1 C, Median (IQR) | 5.90 (5.50–6.50) | 5.50 (5.20–5.80) | < 0.001 |
| TG, Median (IQR) | 115.00 (84.50–170.00) | 103.00 (72.00–150.00) | < 0.001 |
| LDL-C, Median (IQR) | 90.00 (69.50–115.00) | 112.00 (90.00–137.00) | < 0.001 |
| INSULIN, Median (IQR) | 11.19 (6.68–18.90) | 9.35 (5.89–15.41) | < 0.001 |
| HDL-C, Median (IQR) | 1.22 (1.03–1.50) | 1.34 (1.11–1.66) | < 0.001 |
| PFG, Median (IQR) | 111.00 (99.00–129.00) | 99.60 (92.00–109.00) | < 0.001 |
| BMI, Median (IQR) | 28.59 (25.22–32.61) | 27.82 (24.20–32.30) | 0.001 |
| WAIST, Median (IQR) | 104.10 (94.85–115.00) | 97.30 (87.30–108.20) | < 0.001 |
| VAI, Median (IQR) | 157.53 (93.82–240.34) | 125.38 (76.79–209.08) | < 0.001 |
| TyG, Median (IQR) | 8.81 (8.42–9.27) | 8.57 (8.16–9.00) | < 0.001 |
| TG/HDL-C, Median (IQR) | 96.49 (59.75–149.53) | 75.55 (46.20–124.43) | < 0.001 |
| METS-IR, Median (IQR) | 1.82 (1.71–1.93) | 1.70 (1.61–1.81) | < 0.001 |
| HOMA-IR, Median (IQR) | 3.09 (1.74–5.80) | 2.37 (1.42–4.14) | < 0.001 |
| Gender, n (%) | < 0.001 | ||
| Male | 463 (68) | 7,408 (47) | |
| Female | 216 (32) | 8,200 (53) | |
| Race, n (%) | < 0.001 | ||
| Mexican American | 62 (9.1) | 2,531 (16) | |
| Other Hispanic | 44 (6.7) | 1,360 (8.7) | |
| Non-Hispanic White | 454 (67) | 6,896 (44) | |
| Non-Hispanic Black | 74 (11) | 3,177 (20) | |
| Other Race—Including Multi-Racial | 45 (6.6) | 1,644 (11) |
1Median (IQR) or Frequency (%)
2Wilcoxon rank sum test; Pearson's Chi-squared test